Editorial Expression of Concern: The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts - Hichame Id Boufker; Laurence Lagneaux; Mehdi Najar; Martine Piccart; Ghanem Ghanem; Jean-Jacques Body; Fabrice Journé (BMC Cancer)